Circular No. 06/2020/TT-BYT stipulates the system of statistical indicators for pharmaceuticals and cosmetics

Circular No. 06/2020/TT-BYT stipulates the system of statistical indicators in the field of pharmaceuticals and cosmetics, including the list and content of indicators to be collected. This document applies to health authorities from central to local levels.

Số hiệu06/2020/TT-BYT
Loại văn bảnCircular
Cơ quan ban hànhMinistry of Health
Người kýTrương Quốc Cường — Thứ trưởng
Cập nhật14/06/2026
NgànhHealth
Ngày ban hành07/05/2020
Ngày áp dụng01/07/2020
Ngày hết hiệu lực
Tình trạngIn effect
✦ Tóm lược thông minh

Circular No. 06/2020/TT-BYT stipulates the system of statistical indicators in the field of pharmaceuticals and cosmetics, including the list and content of indicators to be collected. This document applies to health authorities from central to local levels.

Đối tượng áp dụng

[The Department of Medicines, the Department of Planning and Finance of the Ministry of Health, Provincial/Municipal Health Departments]

Các điểm cốt lõi

  • The Department of Medicines is responsible for guiding and inspecting the implementation of the Circular (Article 3.1)
  • The Department of Planning and Finance publishes the list of statistical indicators for pharmaceuticals and cosmetics based on reports from the Department of Medicines (Article 3.2.a)
  • Local Health Departments are responsible for collecting and compiling information for statistical purposes to calculate pharmaceutical and cosmetic statistical indicators (Article 3.3)
  • This Circular takes effect from July 1, 2020
  • Relevant agencies and organizations must implement this Circular and report any issues to the Department of Medicines (Article 5)

🌐 Tác động xã hội từ văn bản này

  • Strengthening statistical work in the field of pharmaceuticals and cosmetics helps improve management
  • Local health agencies must undertake additional tasks of information collection, adding administrative burdens to them

❓ Câu hỏi thường gặp

When does this Circular take effect?

This Circular takes effect from July 1, 2020.

What responsibilities does the Department of Medicines have in implementing this Circular?

The Department of Medicines is responsible for guiding, monitoring, inspecting, and establishing reporting systems for statistics in the field of pharmaceuticals and cosmetics.

What role does the Department of Planning and Finance play in this Circular?

The Department of Planning and Finance publishes the list of statistical indicators and collects data for assigned indicators.

Toàn văn

MINISTRY OF HEALTH

SOCIALIST REPUBLIC OF VIET NAM
Independence – Freedom – Happiness

Number: 06/2020/TT-BYT
Hanoi, May 7, 2020

CIRCULAR

Regulations on the system of pharmaceutical and cosmetic statistical indicators

Pursuant to the Law on Statistics No. 89/2015/QH13 dated November 23, 2015;

Pursuant to the Decree No. 94/2016/NĐ-CP dated July 1, 2016 of the Government detailing and guiding the implementation of certain provisions of the Law on Statistics;

Pursuant to the Government's Decree No. 75/2017/NĐ-CP dated June 20, 2017 stipulating the functions, tasks, powers, and organizational structure of the Ministry of Health;

At the proposal of the Director of the Drug Administration Department;

The Minister of Health issues this Circular to regulate the system of pharmaceutical and cosmetic statistical indicators.

Article 1. Scope of Regulation

This Circular stipulates the list and contents of statistical indicators in the healthcare sector concerning drugs (including chemical drugs, herbal drugs, vaccines, biological products except in vitro diagnostic reagents), drug raw materials (including semi-finished herbal products except for herbal drugs), and cosmetics.

Article 2. System of pharmaceutical and cosmetic statistical indicators

The system of pharmaceutical and cosmetic statistical indicators includes:

1. The list of pharmaceutical and cosmetic statistical indicators is prescribed in Appendix I attached hereto.

2. The content of pharmaceutical and cosmetic statistical indicators is prescribed in Appendix II attached hereto.

Article 3. Implementation Organization

1. The Drug Administration Department shall be responsible for:

a) Directing, monitoring, urging, and inspecting the implementation of this Circular;

b) Taking the lead and coordinating with relevant units under the Ministry of Health to establish reporting systems for pharmaceutical and cosmetic statistics to serve the collection of statistical indicators listed in the unified pharmaceutical and cosmetic statistical indicator list nationwide;

c) Organizing the collection, compilation, and submission of reports to the Department of Planning and Finance for consolidation and publication of the list of statistical indicators.

2. The Department of Planning and Finance shall be responsible for:

a) Publishing the list of pharmaceutical and cosmetic statistical indicators based on the reports collected and compiled by the Drug Administration;

b) Collecting and compiling data of the statistical indicators assigned within the system of pharmaceutical and cosmetic statistical indicators and submitting them to the Drug Administration for consolidation.

3. The Department of Health at provincial level is the main agency responsible for organizing the collection and compilation of statistical information within its jurisdiction to serve the calculation of pharmaceutical and cosmetic statistical indicators.

Article 4. Effective date

This Circular takes effect from July 1, 2020.

Article 5. Responsibilities for Implementation

The Heads of the Ministry's Office, Inspectorate, Departments, Bureaus, General Directorates under the Ministry of Health, Directors of Provincial Health Departments, and related agencies, organizations, and individuals are responsible for implementing this Circular. In case of difficulties during implementation, agencies, organizations, and individuals shall promptly reflect such issues to the Drug Administration for consideration and resolution.

During the implementation process, if there are any difficulties, agencies, organizations, and individuals shall promptly reflect such issues to the Drug Administration for consideration and resolution./.

DEPUTY MINISTER
DEPUTY MINISTER
(Signed)
Trương Quốc Cường

Văn bản gốc (PDF)

Mở PDF trong tab mới ↗

Bản đồ quan hệ

Bấm vào một văn bản để mở. Viền đỏ = quan hệ làm thay đổi hiệu lực.